GH
GEVA

GAM Holding’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

GAM Holding’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,400
Closed -$624K – 1187
2015
Q1 		$624K Sell
6,400
-13,600
-68% -$1.44M 0.01% 819
2014
Q4 		$1.86M Buy
20,000
+5,000
+33% +$395K 0.03% 528
2014
Q3 		$1.03M Buy
15,000
+9,000
+150% +$645K 0.02% 700
2014
Q2 		$629K Hold
6,000
– – 0.01% 793
2014
Q1 		$498K Buy
+6,000
New +$555K 0.01% 816
2013
Q4 		– Sell
-6,000
Closed -$380K – 1108
2013
Q3 		$380K Buy
+6,000
New +$295K 0.01% 854

GAM Holding's GEVA Position: Q2 2015 in Review

GAM Holding sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 6,400 shares — an estimated $624K sold.

GAM Holding first reported a position in GEVA in Q3 2013 and held it in 6 quarters. The position peaked at $1.86M in Q4 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • GAM Holding reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • GAM Holding sold 6,400 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $624K.
  • GAM Holding first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2013 and held it in 6 quarters.
  • GAM Holding's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.86M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on GAM Holding's 13F filing for Q2 2015, filed 27 Jul 2015.